Lorenzo Gerratana, Associate Professor of Medicine and Scientific Lead for Breast Medical Oncology at the CRO Aviano National Cancer Institute and the University of Udine, shared a post on X:
“What are the current clinical opportunities of circulating tumor cells in breast cancer? Integration with other liquid biopsy features may guide treatment intensification. Enable biomarker-driven trials for personalized oncology.”
“Mapping breast cancer therapy with circulating tumor cells: The expert perspective”
Authors: Lorenzo Gerratanaa, Caterina Giannic, Eleonora Nicolòc, Letizia Pontolilloc, Francois-Clement Bidardf, Carolina Reduzzic, Massimo Cristofanilli
